期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 一般,3-6周

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

DNA/protein engineering and processing

Synthetic biotechnology

Omics (genomics, proteomics, metabolomics and systems biology)

Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)

Drug delivery and targeting

Nanobiotechnology

Molecular pharmaceutics and molecular pharmacology

Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)

Pharmacokinetics and pharmacodynamics

Applied Microbiology

Bioinformatics (computational biopharmaceutics and modeling)

Environmental biotechnology

Regenerative medicine (stem cells, tissue engineering and biomaterials)

Translational immunology (cell therapies, antibody engineering, xenotransplantation)

Industrial bioprocesses for drug production and development

Biosafety

Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

《當(dāng)代制藥生物技術(shù)》旨在涵蓋制藥生物技術(shù)領(lǐng)域所有最新和杰出的發(fā)展。該期刊的每一期都包括及時(shí)深入的評(píng)論、原創(chuàng)研究文章和該領(lǐng)域領(lǐng)導(dǎo)者撰寫(xiě)的信函，涵蓋制藥生物技術(shù)科學(xué)領(lǐng)域的一系列當(dāng)前主題。歡迎邀請(qǐng)和主動(dòng)撰寫(xiě)評(píng)論文章。該期刊鼓勵(lì)投稿描述藥物發(fā)現(xiàn)和藥理應(yīng)用界面的研究，涉及體外調(diào)查和臨床前或臨床研究。該期刊范圍內(nèi)的科學(xué)領(lǐng)域包括與制藥科學(xué)和生物技術(shù)相關(guān)的藥物化學(xué)、生物化學(xué)和遺傳學(xué)、分子和細(xì)胞生物學(xué)以及聚合物和材料科學(xué)。此外，該期刊還考慮與制藥相關(guān)的食品化學(xué)的綜合研究和研究進(jìn)展。感興趣的領(lǐng)域包括：

DNA/蛋白質(zhì)工程和加工

合成生物技術(shù)

組學(xué)（基因組學(xué)、蛋白質(zhì)組學(xué)、代謝組學(xué)和系統(tǒng)生物學(xué)）

治療生物技術(shù)（基因治療、肽抑制劑、酶）

藥物輸送和靶向

納米生物技術(shù)

分子藥劑學(xué)和分子藥理學(xué)

分析生物技術(shù)（生物傳感、檢測(cè)生物分析物的先進(jìn)技術(shù)）

藥代動(dòng)力學(xué)和藥效學(xué)

應(yīng)用微生物學(xué)

生物信息學(xué)（計(jì)算生物藥劑學(xué)和建模）

環(huán)境生物技術(shù)

再生醫(yī)學(xué)（干細(xì)胞、組織工程和

生物材料

轉(zhuǎn)化免疫學(xué)（細(xì)胞療法、抗體工程、異種移植）

藥物生產(chǎn)和開(kāi)發(fā)的工業(yè)生物過(guò)程

生物安全

生物技術(shù)倫理

歡迎刊登關(guān)于關(guān)鍵主題的特刊，提供有關(guān)前沿研究領(lǐng)域和技術(shù)進(jìn)步的最新綜合信息。

《當(dāng)代制藥生物技術(shù)》是一本重要的期刊，適合希望隨時(shí)了解最新和最重要發(fā)展的學(xué)術(shù)、臨床、政府和制藥科學(xué)家。

《Current Pharmaceutical Biotechnology》(當(dāng)前的制藥生物技術(shù))編輯部通訊方式為BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢(xún)我們的客服老師。我們專(zhuān)注于期刊咨詢(xún)服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。